D. Wade Clapp, MD, is a distinguished professor, the Richard L. Schreiner Professor of Pediatrics, professor of microbiology & immunology, and professor of biochemistry & molecular biology at Indiana University School of Medicine. In 2009, he was appointed chair of the department of pediatrics and physician-in-chief. 

Clapp, a neonatologist and physician/scientist, continues his research which includes NIH grant support focusing on translational research in childhood cancer. In 2008, Clapp and colleagues discovered the first effective therapy for a class of tumors often found in children, that previously were untreatable and potentially life-threatening. Clapp and fellow researchers have subsequently brought two other “first-in-humans” therapies for these same tumors. Clapp grew up on a farm a mile outside of Marysville, Indiana, where he was one of 46 graduates in his rural consolidated high school class. He graduated from Hanover College and the IU School of Medicine. He subsequently did his residency at IU/Riley, and completed neonatology and experimental hematology fellowships at Case Western Reserve University before joining the CWRU faculty. He joined the faculty of Indiana University School of Medicine in 1991 as an early member of the Herman B. Wells Center for Pediatric Research. 

Clapp provides service to several organizations, locally, nationally, and internationally. He leads both local and national diversity scholars programs to train physicians and physician-scientists, he provides service as an officer in the Association of Medical School Pediatric Department Chairs, and he is the chair of the Medical Advisory Board for the Children’s Tumor Foundation. Clapp serves on the board of trustees for Hanover College and is the recipient of their distinguished alumni award. 

David L. Johnson was elected president and chief executive officer of the Central Indiana Corporate Partnership (CICP) in December 2012. CICP is a strategic collaboration of executive leaders committed to developing responsive initiatives to advance inclusive prosperity. 

Under Johnson’s leadership, CICP has formed two new major industry initiatives—AgriNovus for the agbiosciences, and Ascend Indiana for workforce and talent—and has also successfully driven the development of the 50-acre 16 Tech Innovation District, immediately northwest of downtown Indianapolis.

Johnson was one of the founders of CICP’s BioCrossroads life sciences initiative, serving as its president and CEO from 2005 to 2018. While leading BioCrossroads, Johnson raised nearly $400 million dollars in philanthropic, corporate, and venture capital funding; organized and drove the formation of the Indiana Biosciences Research Institute; and forged unique collaborations to advance the national competitiveness of the region’s life sciences and healthcare sectors.

Johnson is a frequent speaker and authoritative source on 21st-century economic development, industry cluster initiatives, and civic leadership and collaboration, with his work cited extensively in recent books such as The New Localism—How Cities Can Thrive in the Age of Populism, and The Oxford Handbook of Local Competitiveness.

Johnson is an honors graduate of Harvard University, Harvard Law School, and Oxford University, where he studied as a Rhodes Scholar.